TRHC’s new pharmacotherapy R&D institute to be based in Orlando
By Akshay Kedari  Date: 2019-02-23

TRHC’s new pharmacotherapy R&D institute to be based in Orlando

The newly established research institute will look forward to forging partnerships with significant pharmaceutical and academic entities in the region.

Tabula Rasa HealthCare, Inc., the renowned healthcare technology firm, has made it to the headlines for having declared the launch of its new Scientific Precision Pharmacotherapy Research and Development Institute. Reportedly, the Institute will be based out of Orlando, within Lake Nona Medical City.

According to sources familiar with the knowledge of the matter, TRHC's Research & Development Institute is strongly dedicated to developing proprietary products. These products apparently, will be aimed toward the optimization of medication regimes in order to reduce medical care expenditure, enhance patient outcomes, lower the healthcare service utilization, and manage risk. The Institute will also ensure the validation and recognition of these products from the scientific and regulatory communities.

Reportedly, the research vision of the TRHC Institute expands with the new research initiatives cropping up, inclusive of biomedical engineering systems, translational research, patient-specific information, nanoscale science, data-driven technologies and solutions, and bioinformatics.

According to an official press release by Tabula Rasa HealthCare, Calvin H. Knowlton, the CEO & Chairman of the company, stated that the new research institute intends to focus on enhancing the firm’s decision support tools via extensive research, deploying computer simulations, computational modeling, and pharmacokinetics & pharmacodynamics modeling. The basic objective here is to optimize and manufacture novel products in association with the company’s Medication Risk StratificationTM and Medication Risk MitigationTM technologies, Knowlton claimed.

Dr. Jacques Turgeon, Chief Scientific Officer, TRHC, stated that the institute will aim to forge partnerships with academic and pharmaceutical entities, and also look forward to the opportunity to join hands with globally acclaimed organizations.

Commenting further on the launch, Knowlton affirmed that the company is thrilled to not only be a part of the innovation prevalent in Lake Nona Medical City, but also to have gained the guidance of Dr. Michaud and Dr. Turgeon, stalwarts recognized for their expertise in pharmacokinetics & drug-metabolism and research and pharmacy education respectively.

Dr. Jacques Turgeon, BPharm, PhD, for the record, has been named the CEO of the TRHC Institute, while Dr. Veronique Michaud, BPharm, PhD, will be filling in the place of the institute’s Chief Operating Officer.

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Alaskans to use tax credits to aid energy efficiency & air quality
Alaskans to use tax credits to aid energy efficiency & air quality
By Akshay Kedari

Local government authorities in Alaska have reportedly approved a bill that allows the creation and utilization of property tax credit to enhance air quality and energy efficiency. Sources cite that the Senate has accepted the bill with a 17-1 vote a...

Liteye gets $3M production order as part of US Defense Industrial Base
Liteye gets $3M production order as part of US Defense Industrial Base
By Akshay Kedari

Liteye Systems, a renowned leader in CUAS (Counter Unmanned Aerial Systems), has reportedly announced the receipt of an additional specialty production order for approximately $3 million. The contract would further make sure delivery of hardware for ...

Turning Point Brands offers free sanitizer bottles to combat COVID-19
Turning Point Brands offers free sanitizer bottles to combat COVID-19
By Akshay Kedari

From offering medical aids to donating funds, many companies worldwide have come forward to help governments and people to fight the spread of the novel coronavirus. Recently, Turning Point Brands, one of the leading tobacco product manufacturers in ...

Isracann enters JV agreement to develop cannabis production in Israel
Isracann enters JV agreement to develop cannabis production in Israel
By Akshay Kedari

Isracann Biosciences Inc. has recently entered a joint venture agreement for phased partnership of 2 near-term farm operations at the Sharon Plain region in Israel. This JV agreement will provide significant revenue generating opportunities to the Is...

Russia to track people at risk of COVID-19 through their geolocation
Russia to track people at risk of COVID-19 through their geolocation
By Akshay Kedari

Mikhail Mishustin, the Russian Prime Minister, recently gave the regional authorities 5 days for developing a system that can track citizens by using mobile phone geolocation data. The move is aimed at tracking people who have come into contact with ...